Precision NanoSystems to Present at the 39th Annual Meeting & Exposition of the Controlled Release Society, July 15-18, 2012

Press Release

July 20, 2012

Precision NanoSystems, a provider of innovative tools for the development and manufacture of best-in-class nanoparticles for use as medicines, and in medical research, has been selected to present as part of the Soapbox Sessions at the Controlled Release Society (CRS) 39th Annual Meeting & Exposition that will take place at the Centre des congress de Québec, Québec City, Canada from the 15-18 July, 2012.

The CRS Soapbox Sessions introduce the latest, most novel technologies, products and services for delivery science. Euan Ramsay, COO, Precision NanoSystems will describe the NanoAssemblr manufacturing platform for the production of next-generation lipid nanoparticles during Session III on Sunday, July 15, 2012 from 2.30 PM – 3:10 PM.

About Precision NanoSystems, Inc.

At Precision NanoSystems we are creating innovative tools for the development and manufacture of best-in-class nanoparticles for use as medicines, and in medical research. Our proprietary NanoAssemblr platform enables the simple, rapid, reproducible, and scalable manufacture of next-generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to difficult-to-access cells and tissues in the body. We provide instruments, reagents and services to life sciences researchers and build strategic collaborations to revolutionize healthcare through nanotechnology. To join the revolution visit our website.


IN THE NEWS

Press Release

Precision NanoSystems (PNI) is excited to be participating in this year’s SfN conference, Nov. 15th to 19th in Washington, DC. The Walter E. Washington Convention Center will play host to over 30,000 d...

Read More


Press Release

Vancouver, BC, Apr 20, 2021 - Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, today launched the GenVoy-ILM™ T Cell Kit for mRNA to enable lipid nanoparticle (LNP)-based ex vivo gene transfer. ...
Read More